| Position | Action |
|---|---|
| At current $356 price level | Trim 10% of existing JPM exposure |
| Weekly close below $345 (intermediate deterioration) | Reduce position size by additional 25% and reassess |
| Daily close $348-$353 with MACD histogram bottoming AND RSI bouncing from sub-60 levels | Add 1-2% portfolio only (not aggressive add) |
| Confirmed breakout above $362.81 with positive MACD histogram and RSI >65 | Re-load toward Hold/Overweight |
The fundamental and macro setup for JPM is the most powerful it's been in years, and the stock is breaking out of a structural base to prove it.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $353.32 | bullish |
| 50 SMA | $331.10 | bullish |
| 200 SMA | $310.49 | bullish |
| RSI (14) | 62.21 | neutral |
| MACD | 7.08 | bearish |
| MACD Signal | 7.18 | bearish |
| MACD Histogram | -0.10 | bearish |
| Bollinger Upper Band | $363.05 | — |
| Bollinger Middle (20 SMA) | $348.35 | — |
| Bollinger Lower Band | $333.65 | — |
| ATR (14) | $7.30 | — |
Support: 353.32 · 348.35 · 333.65 · 331.1 · 310.49 | Resistance: 363.05 · 362.71 · 359.24
JPMorgan Chase (JPM) closed at $356.30 on 2026-08-06 after tagging but rejecting the Bollinger Upper Band at $363.05 with an inverted hammer candle, signaling short-term exhaustion. The medium- and long-term trends remain structurally bullish with price well above the 50 SMA ($331.10, +7.6%) and 200 SMA ($310.49, +14.7%) in a golden cross regime. However, a fresh MACD bearish cross (7.08 vs signal 7.18, histogram -0.10) and RSI cooling from 66 to 62 suggest momentum is decelerating near-term. Tactical support sits at the 10 EMA ($353.32) and Bollinger midline ($348.35), while the 50 SMA at $331.10 represents the major trend line. Traders are advised to trim long exposure, trail stops to $348.35, and await either a pullback-to-support confirmation or a fresh breakout above $363.05 before committing fresh capital.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight: Trim 10% at $356 to capture asymmetric downside while preserving core compounders
Underweight with 10% trim is the calibrated synthesis: responsive to the stretched-but-not-extreme setup prescription, conservative enough to avoid over-trim errors, respects the structural floor the bull case correctly defends, and captures the asymmetric downside from premium valuation with no defensive cushion, decelerating sequential trends, deteriorating technicals, and incomplete sentiment data.
When: Confirmed close above $362.81 with positive MACD histogram and RSI >65
Then: Full re-engagement toward Hold/Overweight
↩ rebuts: “Bear technical caution ignoring operating reality”
· concedes: For a trader with a 2-week horizon, trimming here and waiting for $348 is rational; The MACD cross and Bollinger rejection are valid caution signals for short-term traders
JPM's bull case is built on statistical illusions and peak macro conditions that are already priced in, while sequential deceleration across revenue, NII, and operating metrics—combined with technical distribution signals and an imminent credit cycle—create asymmetric downside risk to $320-330.
→ vs conservative: MACD rolling from +8.31 to +7.08 and inverted hammer at $362.81 represents healthy uptrend pause, not distribution; RSI of 62 is strong-trend behavior not overbought exhaustion
→ vs conservative: 88% probability of no Fed cuts in 2026 with near coin-flip on September hike is actually bullish for JPM's asset-sensitive balance sheet and net interest income expansion, not a reason to reduce exposure
→ vs conservative: The conservative view is 'catastrophically wrong' on macro because higher-for-longer directly expands JPM's NIM
→ vs neutral: Waiting for confirmation when franchise has multiple compounding vectors (Klarna partnership, Dimon's infrastructure alliance, research desk target resets) is unnecessary caution that will cause investors to miss the move
Market Cap
$947.12 billion
PE Ratio (TTM)
15.27x
Forward PE
14.25x
PEG Ratio
1.72
Price to Book
2.68x
EPS (TTM)
$23.34
Forward EPS
$25.01
Book Value
$133.01
Revenue (TTM)
$186.33 billion
Net Income (TTM)
$63.63 billion
Profit Margin
34.92%
Operating Margin
50.39%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
Total Assets
$4,900.48 billion
Stockholders' Equity
$364.04 billion
Tangible Book Value
$279.70 billion
Total Debt
$516.81 billion
Long-Term Debt
$448.76 billion
Beta
0.977
52-Week High
$362.71
52-Week Low
$279.10
50-Day Average
$328.70
200-Day Average
$312.11
Dividend Yield
~1.85%
Buybacks (annualized)
~$33 billion
Total Shareholder Yield
~5.4%
Q2'26 Diluted EPS
$7.70
Q2'26 Total Revenue
$49.83 billion
Q2'26 Net Income
$16.49 billion
Q2'26 Net Interest Income
$25.37 billion
Interest Expense (Q2'26)
$23.83 billion
Cash & Equivalents
$312.14 billion
Trading Securities
$814.30 billion
Goodwill & Intangibles
$64.29 billion
Retained Earnings
$428.21 billion
Ordinary Shares
2.68 billion
Leverage Ratio
~13.5x
Recommendation
BUY/HOLD
Strengths
Concerns
JPMorgan Chase & Co. represents a high-quality blue-chip financial with industry-leading profitability metrics including a 17.79% ROE and 34.92% net margin, supported by a fortress balance sheet of $4.9T in assets and $364B in equity. The Q2'26 quarter demonstrated accelerating performance with $49.83B in revenue (up ~10% sequentially) and $7.70 diluted EPS (up ~47% YoY), driven by NII expansion and strong capital markets activity. The bank returns approximately 5.4% annually to shareholders through dividends and buybacks, though the stock trades at a premium valuation (15.27x P/E, 2.68x P/B) relative to peers. BUY/HOLD recommended as a core long-term holding, with tactical entry points near the 50-day MA (~$329) or 200-day MA (~$312) offering better risk-reward than chasing current levels near $356.